We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Urology

Journal Scan / Research · December 22, 2021

MyProstateScore to Rule Out Clinically-Significant Cancer in Men With PI-RADS 3 Multiparametric MRI



Additional Info

Urinary MyProstateScore (MPS) to rule out clinically-significant cancer in men with equivocal (PI-RADS 3) multiparametric MRI: addressing an unmet clinical need
Urology 2021 Dec 11;[EPub Ahead of Print], JJ Tosoian, U Singhal, MS Davenport, JT Wei, JS Montgomery, AK George, SS Salami, SG Mukundi, J Siddiqui, LP Kunju, BP Tooke, CY Ryder, SP Dugan, Z Chopra, R Botbyl, Y Feng, MS Sessine, NW Eyrich, AE Ross, BJ Trock, SA Tomlins, GS Palapattu, AM Chinnaiyan, YS Niknafs, TM Morgan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.

Further Reading